CD22L-N3
CD22L-N3 (BPC-Sia-LacNAc-N3) is a pharmaceutical intermediate that can be used to synthesize CD22-specific trisaccharide ligands. CD22L-N3 is applicable to the research of B-cell lymphoma.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1019642-47-7
- Formule: C40H54N6O19
- Masse moléculaire:922.90
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1019642-47-7
-
Masse moléculaire 922.90
-
Formule C40H54N6O19
-
SMILES
O(C[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@@H](OCCN=[N+]=[N-])[C@H](NC(C)=O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O)[C@@]3(C(O)=O)O[C@@]([C@@H]([C@@H](CNC(=O)C4=CC=C(C=C4)C5=CC=CC=C5)O)O)([C@H](NC(C)=O)[C@@H](O)C3)[H]
-
Synonyms
BPC-Sia-LacNAc-N3
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)